CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Slides:



Advertisements
Similar presentations
Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Advertisements

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
CVD risk estimation and prevention: An overview of SIGN 97.
Using EHRs to Understand and Reduce Racial and Ethnic Disparities in Diabetes Care: the Translating Research into Action for Diabetes (TRIAD) Study Arleen.
IDC 4.1 Problems n High incidence and prevalence of diabetes n Reliance on primary care providers n Significant variation in practice n High costs and.
Integrated Disease Management at HealthPartners Health Care Transformation Task Force Meeting August 16, 2007 N. Marcus Thygeson, MD Associate Medical.
Competitive Grant Program Core Elements Evaluation Overview Yvette Roubideaux, MD, MPH.
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 3 SDPI Healthy Heart Project.
RPMS Survey Results SDPI Competitive Grant Program.
CVD Risk Reduction Group Case Management Documentation of Care Plans May 2005.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
CVD Risk Reduction Group Diabetes Registries May 2005.
Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.
SDPI Competitive Grant Program Planning Meeting 1 IHS Diabetes Competitive Grant Program: Overview and Update Kelly Acton, MD, MPH, FACP Director, IHS.
IHS Special Diabetes Program Competitive Grants Part 2: Using Idea Maps to Plan for Evaluation CVD Risk Reduction Group Cynthia C. Phillips, Ph.D. Lisa.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
Core Elements.  Recruitment Goals = 48 new participants each year  Recruitment for Intensive Activities 1. Recruitment Team 2. Team Meetings  Invitation.
Core Elements: Case Management Recruitment Yvette Roubideaux, MD, MPH.
Core Elements: DPP Curriculum DP Recruitment Yvette Roubideaux, MD, MPH.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
Key Elements of Case Management Charlton Wilson MD SDPI Competitive Grant Program Cardiovascular Disease Risk Reduction Group Planning Year – Meeting 1.
CVD Risk Reduction Group Screening and Eligibility Core Elements Draft July 2005.
Dr. Sevil Huseynova World Health Organization
CVD Risk Reduction Group Case Management Core Elements: Update July 2005.
CVD Risk Reduction Group Case Management Core Elements May 2005.
Diabetes Mellitus Type 2
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
CCC Team Assessment of Care Coordination Capacity February 26, 2014 Care Coordination Collaborative California Institute for Mental Health Care Coordination.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Recall and Reminder.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
1 The Three Phases of Collaboration: Chronic Disease Management, Cancer Prevention, and Capacity Kim Salamone, Ph.D. Vice President, Health Information.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
A Coordinated Approach to Cardiovascular Care Sharon Levine MD Associate Executive Director The Permanente Medical Group Kaiser Permanente Bay Area Council.
IMPROVING DIABETES CARE FOR ADULTS: A Population-Based Approach Patrick J. O’Connor, MD, MPH Senior Clinical Investigator HealthPartners Research Foundation.
Using Healthy Heart Data by Rick Frey, PhD Toiyabe Indian Health Project, Inc. A collection of PowerPoint slides that have been used in grant applications,
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Northern England Strategic Clinical Network Conference 15 th May 2015.
QUALITY … … the final frontier. Quality in Family Practice Purpose: “To recommend and pilot test a programme in Ontario which promotes and celebrates.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Q UALITY M EASURES W ORKGROUP Apr 12, Stage 1 CQMs Core Measures Alternate Core Menu Set Stage 1 Clinical Quality Measures.
Healthy Heart Initiative and the Role of the Pharmacist Alexis Beyer, PharmD, NCPS Cherokee Indian Hospital Healthy Heart Pharmacist.
ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
CVD MEETING 7/9/01: main topics CV CLINIC WITH SCREEN SHOTS AND AUDIT MANAGEMENT PROTOCOL WITH DRUGS AND RISK CALCULATION CHARTS ASPIRIN AUDIT.
Stroke epidemic in Pakistan Mohammad Wasay, MD, FRCP, FAAN Aga Khan University.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Improving IPC Clinical Measures Model for Identifying Areas for Improvement Colleen A. Hayes MHS, RN IPC Learning Session #2 Denver, CO.
Non-communicable diseases (NCDs) include:
At the end of this talk, the resident will be able to:
Non-communicable diseases (NCDs) include:
Diabetes Health Status Report
Cardiovascular Disease (CVD) in Texas
SC PA Data Review Robert A. Gabbay, MD, PhD
Systolic Blood Pressure Intervention Trial (SPRINT)
Select Topics in Cardiovascular Medicine
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
RCHC’s Cardiovascular Health Initiative
Many post-MI patients are not receiving optimal therapy
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention

Overview Standards of Care Current Quality of CVD Care Purpose of Competitive Grant Program Case Management Tools

Standards of Care  IHS Standards of Care for Patients with Type 2 Diabetes (August 2003) Includes recommendation for treatment of CVD Risk Factors Target BP < 130/80 mm Hg LDL < 100 mg/dl Antiplatelet Therapy Tobacco cessation Self-Management Education

Standards of Care  IHS Best Practice Models Cardiovascular Disease and Diabetes Suggested practice models, levels of service and components of care Additional information on standards, target for treatment

Impact of CVD  Number 1 cause of death in AI/ANs  People with diabetes are 3-4 times more likely to develop CVD  Prevalence, mortality increasing  Level of awareness of the link between diabetes and CVD needs to be raised

Quality of Care - CVD Risk Reduction in AI/ANs with Diabetes  Evidence/Data IHS Diabetes Care and Outcomes Audit

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics A1C, % Mean A1C, *p< comparing mean HbA1 levels in FY94 and FY04

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics A1C, % Glycemic control, *p< comparing mean HbA1 levels in FY94 and FY04

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Performance Measure: Dyslipidemia Assessment Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Mean Lipid Values mg/dl

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Blood Pressure Control Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Blood Pressure Control Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Tobacco Use Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Aspirin Therapy Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Self Management Education Percent

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Self Management Education Percent

CGP CVD Risk Reduction Demonstration Project  Purpose: To implement an intensive, clinic based case management approach to CVD Risk Reduction in individuals with Diabetes Demonstration Project - Intensive treatment to target goals based on standards of care  Eligibility for Intensive Activities Adults with Diagnosis of Diabetes With or without CVD Exclusions (pregnant, ESRD, alcohol/substance abuse)

Core Elements: Case Management  Case Management Team  Case Management Strategy Individual case management Disease management Self-management education  Tools for Case Management Diabetes Registries Diabetes Management System/RPMS Integrated Case Management System

Role of Data Systems in Improving Patient Care in Diabetes  Individual Patient Level  Track one or many patients  Identify specific clinical information  Reminders/prompts  Population Level  Calculate rates  Measure performance  Improve systems

Diabetes Management System  DMS Package in RPMS  Several applications to view individual patient data  Screen access for direct data entry  “Integrated” , recall

Diabetes Management System  Diabetes Registry  Data Items Maintained in the Diabetes Registry  - Patient Status  - Type of Diabetes  - Complications  - Register Provider and Case Manager  - Facility Where Patient is Routinely Followed  - Family Members  - Last and Next Case Review Dates  - Recall Date (Optional)

Diabetes Management System  Diabetes Registry Lists  Patient Status  Active, Inactive, Transient, Lost to Followup, Unreviewed, Deceased, Non-IHS Care  Diagnosis  Type 1, Type 2, Gestational, IGT  Complications  CVA (Stroke), Myocardial Infarction, End Stage Renal Disease, Hypertension, Retinopathy, Laser Treatment for Retinopathy, High Risk Foot, Minor Amputation, Major Amputation(s)

Diabetes Management System  Diabetes Patient Care Summary  Used by provider to manage/update care during clinical encounter  “Electronic” flowsheet – to do lists for recommended care  A part of Adult Health Summary  Electronic Audits using DMS/RPMS  Nationally defined audit elements  Integrated Case Management Package  Documentation of care plans, in development

Capacity to Use DMS in CGP  RPMS Survey – CGP CVD Grant Programs QuestionPercent Sites using RPMS92 Sites with DMS Package installed90 Sites using DMS76 Sites conducting electronic audits45

Next Steps  Treatment of CVD Risk Factors  As a part of intensive case management strategy  Grantee Panel discussion/questions  Core Elements: Case Management  Draft protocol/required elements for discussion  Explore DMS as an option  May need to schedule additional training  Use of paper tracking until everyone using  Need to consider those not on RPMS